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Background: The growing popularity of offending behavior programs has led to the interest of whether such
programs are effective with mentally disordered offenders. This study aimed to evaluate the effectiveness of the
Reasoning and Rehabilitation program adapted for offenders with severe mental illness (R&R2 MHP).
Methods: A sample of 59 adult high risk males detained in a high secure hospital completed questionnaires at
baseline and post treatment to assess violent attitudes, anger, coping processes and social problem-solving. An
informant measure of social and psychological functioning, including disruptive behavior, was completed by staff at
the same time. The data of 30 patients who participated in the group condition were compared using intention to
treat analysis with 29 controls who received treatment as usual.
Results: 80% of group participants completed the program. In contrast to controls, significant medium-large
treatment effects were found at outcome on self-reported measures of violent attitudes, social problem-solving and
coping processes. Improvements were endorsed by informant ratings of disruptive behavior, social and
psychological functioning.
Conclusions: The R&R2MHP had a comparatively low dropout rate and was effective in a sample of high risk
mentally disordered offenders requiring detention in high security. Future research should use a randomized
controlled design.
Trial registration: Current Controlled Trials ACTRN12613000216718.
Keywords: Mentally disordered offenders, Treatment outcome, Reasoning & Rehabilitation, Cognitive skillsBackground
Individuals with severe mental illness (SMI) are at an in-
creased risk of committing violent crimes. This is a ro-
bust finding supported by a variety of studies using a
range of different methodologies including: population
cohort studies [1-4]; community prevalence studies [5,6]
and retrospective studies [7,8]. This is also evidenced by
the high occupation of forensic inpatient beds by those
who have SMI [9]. To alleviate this pressure and as prison
and hospital populations rise, there is an increased de-
mand for evidence-based treatments designed to reduce
antisocial behaviors in those with SMI.* Correspondence: susan.young@kcl.ac.uk
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reproduction in any medium, provided the orResearch indicates that predictors of recidivism are
similar for offenders with and without mental disorder
[10,11]. These shared predictors include: maladaptive be-
liefs and attitudes supporting a criminal lifestyle [12,13]
and poor social problem-solving ability [14-17]. Indeed,
pro-criminal thinking has emerged as the strongest pre-
dictor for offending behavior [18-20]; others include in-
stitutional violence [21], poor psychosocial functioning
and treatment engagement [22]. The association with anger
is less clear; some research has reported it is a greater pre-
dictor of aggressive behavior than pro-criminal attitudes
whereas other research suggests it is not necessarily associ-
ated with aggressive behavior [23,24].
Detainment is the most conventional method of dis-
posal for those who commit severe criminal offences, yet
there is paucity of research reviewing how offenders. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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offending after release from prison. Zamble and Porporino
[25] propose that an individual’s ability to cope with life
circumstances is a critical factor for future adaptation. In
their investigation of coping behaviors in imprisoned of-
fenders, they found that offenders exhibited poor coping
behaviors which maintained criminal behavior and more-
over led to recidivism.
Treating high risk offenders
Mentally disordered offenders (MDOs) with complex clin-
ical needs and severe aggression are commonly detained
in high secure hospitals. They are considered ‘high risk’ as
they pose a grave and immediate danger to the public (De-
partment of Health, 2006). Compared with those from
low and medium secure hospitals, these patients have a di-
verse and complex range of psychiatric and criminogenic
needs, often presenting with high rates of comorbidity and
difficulty engaging with their clinical care [26,27].
Martinson [28] sparked debate after claiming that
nothing worked in offender rehabilitation. This led to
closer investigations of the efficacy of offender rehabili-
tation programs and has subsequently contributed to an
amassing wealth of ‘what works’ research [29], which in-
dicates that treatments targeted towards rehabilitating
offenders are effective. Blud et al. [30] suggested that redu-
cing recidivism was possible if interventions were appro-
priately designed, focused towards aims and delivered in a
systematic manner.
Since then, a growing interest has developed in the ef-
fectiveness of Offending Behavior Programs (OBPs), the
most common being the 22-session Enhanced Thinking
Skills and the 36-session Reasoning and Rehabilitation
[R&R] programs [31,32]. Both these OBPs employ a
cognitive-behavioral paradigm which has been shown to
be effective for reducing recidivism rates in juveniles and
adult offenders [33,34]. However, these OBPs have not
been designed to meet the complex needs of MDOs.
Whilst a treatment effect was reported for clinical out-
comes in a randomised control trial of the original R&R
program, there was a 50% attrition rate of those allo-
cated to the treatment condition [35]. This is important
from a risk perspective, as research suggests that
recidivism rates are elevated amongst non-completers
[36-38]. Antisocial personality disorder, recent violence
and psychopathy have been found to predict dropout [35].
High rates of treatment dropout call into question
whether OBPs with a general offending focus are relevant
and responsive to the needs of MDOs. The Risk Need
Responsivity model suggests that structured and targeted
programs should be delivered with the aim to match content
and pace of treatment with specific offender character-
istics [39]. Consistent with this theoretical paradigm, R&R
has been adapted to meet the needs of MDOs (R&R2MHP)[40]. Firstly, the program duration was reduced from 36 to
16 sessions but supplemented by individual sessions pro-
vided by a mentor. The mentor role was introduced to im-
prove treatment completion [41] and support the patient
to rehearse and consolidate newly acquired skills and
transfer them into daily activities. Secondly by inclusion of
a module that addresses the executive dysfunction (such
as attention and memory problems, poor organizational
and planning skills) commonly experienced by many pa-
tients with SMI and that may interfere with their ability
to effectively engage in OBPs [42].
Research has indicated that R&R2MHP is a feasible
and effective treatment for MDOs [43,44]. A controlled
multi-site study of patients detained in medium and low
secure services reported a completion rate of 78% and
positive clinical changes on self-reported measures of ra-
tional problem-solving, anger and attitudes towards vio-
lence. Improvement was supported by informant ratings
of social and psychological functioning.
An evaluation of a similar program (R&R2 for ADHD
Youths and Adults) in MDOs with a primary diagnosis
of personality disorder detained in a high secure service
has also shown a positive treatment effect, together with
a 76% program completion rate [45]. However feasibility
and effectiveness of R&R2MHP has yet to be investigated
in high risk MDOs with a primary diagnosis of SMI. Fur-
thermore, the treatment effect for improving coping pro-
cesses in high risk MDOs has yet to be established. This
study therefore evaluated the R&R2MHP in such patients
using a quasi-experimental design comparing group par-
ticipants with waiting list controls. The following research
questions were investigated:
1. How successful is the program in terms of retention of
participants in a high secure setting?
Consistent with the findings of Rees-Jones et al. [43],
it was hypothesised that the completion rate would be
greater than the 50% reported by Cullen et al. [35] in
their study using the original 36 session R&R program.
2. Is the program effective in patients detained in a high
secure setting?
Compared to controls, it was hypothesised that group
participants would show significant improvements in vio-
lent attitudes, anger, coping processes, social problem-
solving, disruptive behavior and social functioning.
Methods
Design and participants
The quasi-experimental controlled study involved the par-
ticipation of 59 male patients with SMI detained under the
U.K. Mental Health Act (1983) in a high secure hospital
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tion (R&R2MHP). A total of five groups were delivered for
this study. Their data were compared with that of 29 con-
trols who received treatment as usual (TAU) (see Figure 1).
All participants were referred by their clinical team to
attend the OBP. Inclusion criteria were age 18–65, a his-
tory of SMI (e.g. schizophrenia, schizoaffective disorder,
bipolar disorder), a history of violent or antisocial behav-
ior, no previous experience of participating in R&R, pro-
ficiency in English language. Exclusion criteria included
intellectual disability, patients who were mentally unstable
and/or who posed a risk of violence to the researcher.
Intervention
R&R2MHP [40] is a manualised cognitive-behavioral inter-
vention developed for antisocial youths and adults with
mental health problems. It consists of 16, 90-minute, ses-
sions which run on a weekly basis. It is a revised version of
the original 36-session R&R program and aims to reduce
anti-social behavior and attitudes and improve pro-social
thinking, cognitive and problem-solving skills. The program
employs a variety of methods to engage individuals such
as individual group exercises, audiovisual material and
workbooks which include homework assignments. The
program consists of 5 treatment modules: (1) a neuro-
cognitive model which introduces techniques to in-
crease attentional control, impulse control, memory and
constructive planning; (2) a problem-solving module which
encourages problem identification, generation of multiple
alternative solutions and consequential thinking; (3) anRecruite
N
Time 1– allocated to treatment  
condition and assessed at baseline: 
N=30
Time 2 Assessment N=28
Missing self-report data N=2
Missing informant data N= 4
Did not complete treatment N=6
ITT analysis N=30
Imputed data at Time 2:
N=2 self-report and N=4 informant 
report data 
Figure 1 Flowchart of patient participation.emotional control module which involves management of
anxiety, anger and conflict; (4) a social skills module which
aims to increase awareness of the thoughts and feelings of
others; and (5) a critical reasoning module which aims to
develop skills in the assessment and evaluation of infor-
mation. The R&R2MHP program combines group and in-
dividual treatment. Individual treatment incorporates the
use of a mentoring paradigm, whereby a mentor provides
coaching sessions outside of group sessions. Their purpose
is to facilitate the transfer of skills learned in group sessions
into daily activities. Mentors are provided with written
guidance on how to structure individual sessions. R&R2
MHP facilitators were provided with training in how
to deliver the program. Program integrity and consistency
was ensured through (1) establishing a steering committee,
where regular meetings were held and supervision was
provided by SY (the program author); (2) random observa-
tions of group sessions by one of the program authors
(SY); and (3) group supervision meetings of facilitators to
prepare for sessions, process and discuss sessions that had
been delivered and (4) regular meetings and supervision
between program facilitators and mentors. Furthermore,
R&R2MHP maximised program integrity by fostering con-
sistency through its structured, manualised design.
Treatment completion
A cut-off of ≥12 sessions was used to classify patients as
completers, following the recommendation made by
Cullen et al. [46] and representing 80% attendance of
the programme.d to study
 = 59
Time 1– allocated to control 
condition and assessed at baseline:
N=29 
Time 2 Assessment N=20
Missing self-report data: N= 9
Missing informant data: N=11
Included for ITT analysis: N=29
Imputed data at Time 2:
N=9 self-report and N=11 informant 
report data
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Control participants were not asked to refrain from attend-
ing interventions considered to be part of their usual treat-
ment. However they were not permitted to attend the
R&R2MHP program or similar cognitive skills interven-
tions during the course of the study. Common psychosocial
interventions included group and individual occupational,
psycho-educational and cognitive-behavioral interventions
for psychosis, personality disorder, violence, sex offending,
substance misuse and relapse prevention.
Measures
Baseline assessments
Demographic information, diagnosis, offence and admis-
sion history were obtained from clinical file reviews at the
start of the study. In addition participants completed the
Psychotic Symptoms Rating Scale (PSYRATS) [47] to assess
severity of psychotic symptoms and the structured clinical
interview for DSM-III-R personality disorders (SCID II)
[48] to assess antisocial personality characteristics.
Outcome measures
The following measures were administered at baseline
(Time 1) and repeated 16 weeks later post group (Time 2)
to assess the primary (violent attitudes) and secondary out-
comes (coping skills, social problem-solving, reaction to
provocation, disruptive behavior and social functioning).
The primary outcome measure was determined prior to
commencement of the study. All measures were self-rated,
except for the informant-rated Disruptive Behavior and So-
cial Problem Scale (DBSP). The same informant (a mem-
ber of the clinical team) completed the DBSP at Time 1
and Time 2.
1. Maudsley Violence Questionnaire (MVQ) [49] is a
56-item self-reported measure of cognitive style in
relation to violent attitudes. It has two constructs:
machismo (42 items which assess the extent to which
the individual supports stereotypes of males as being
dominant and tough) and acceptance (14 items which
assess the acceptance of violence). A total score can
be obtained by summing the scale scores (score range
0–56). High internal-consistency reliability for both
constructs was estimated by Cronbach’s alpha
(ranging between 0.74 and 0.91) in a male student
sample [49] and it has specified differences between
mentally disordered offenders [43,44].
2. Novaco Anger Scale - Provocation Inventory: Reaction
to Provocation/Personal Affect Questionnaire (NAS-PI)
[50] is a 48-item self-reported measure that assesses
cognitive, arousal and behavioral domains of anger
experience. Each item is rated on a 3-point Likert scale
with higher scores indicating greater endorsement of
anger (scores range between 16–48 for each domain); atotal score can also be obtained by summing the
domain scores (score range 48–144). The NAS-PI has
good test-retest reliability (Cronbach’s alphas ranged
from 0.78 to 0.91), concurrent validity, and the NAS
total score has excellent internal-consistency
(Cronbach’s alpha 0.92) [51,52]. It has been effective
in predicting violence in MDOs [53] and
discriminating between aggressive patients and
non-clinical controls [54].
3. Ways of Coping Scale (WAYS) [55] is a 66-item
self-reported measure of coping processes with
responses. Participants are asked to recall a stressful
situation that they have experienced in the past
week. They are informed that this may be a situation
that was difficult or troubling for them, either
because they felt distressed about what happened, or
because they had to use considerable effort to deal
with the situation. They are told that the situation
may have involved their family, work, friends or
something else important to them. They are then
asked to rate how often they used suggested
behaviors to cope with that particular stressor on a
4-point Likert scale. The WAYS includes eight
constructs, each with good internal consistency
estimated by Conbach’s alpha as follows: (1)
confrontive coping, 0.70; (2) distancing, 0.61; (3)
self-controlling, 0.70; (4) social support, 0.76; (5)
accepting responsibility, 0.66; (6) escape avoidance,
0.72; (7) planful problem-solving, 0.68; and (8)
positive reappraisal, 0.68 [56]. In addition a total
score can be obtained by summing the scale scores.
The higher the score, the more effort the person
applies to the coping process.
4. Social Problem-Solving Inventory-Revised: Short
(SPSI-R: S) [14] is a 25-item self-reported
questionnaire with responses rated on a 5-point
Likert scale that assesses people’s ability to solve
problems in everyday life. It consists of five subscales,
two measuring problem-solving orientation (positive
and negative) and three assessing problem-solving
style (rational problem-solving, impulsivity/
carelessness and avoidant). Scores range between
0–20 for each domain. An adjusted total score was
obtained (score range 0–20) with higher scores
reflecting better social problem-solving ability. This
measure is reported to have high test-retest reliability
(Cronbach’s alphas ranged from 0.68 to 0.91) and
internal consistency (Cronbach’s alphas ranged from
0.69 to 0.95) [57].
5. Disruptive Behavior and Social Problems Scale
(DBSP) [58] is an informant-rated questionnaire
consisting of 14 statements rated on a 7-point Likert
scale relating to patient’s behavior and social
interactions. The scale consists of two factors, (1)
Table 1 Participant characteristics comparing group
participants (R&R2MHP) and controls (TAU) at
baseline (Time 1)
R&R2MHP group TAU group
N M (SD) N M (SD) t-value
Age 30 37.93 (10.10) 29 38.72 (9.70) −0.31
Range 22-63 Range 20-66
Number of previous
admissions
30 4.07 (4.56) 29 3.24 (4.64) 0.69
Range 0-15 Range 0-20
Number of previous
convictions
30 10.47 (14.45) 29 14.00 (20.30) −0.77
Range 0-65 Range 0-100
PSYRATS total 30 7.87 (14.00) 29 2.79 (10.50) 1.57
SCID-II total 30 30.27 (12.48) 29 34.59 (9.78) −1.48
MVQ total 30 15.83 (12.02) 29 18.14 (13.45) −0.69
NAS-PI total 30 77.27 (16.78) 29 79.24 (15.74) −0.47
WAYS total 30 46.90 (22.42) 29 42.82 (24.86) 0.66
SPSI total 30 12.39 (3.36) 29 11.57 (2.49) 1.07
DBSP total 26 35.59 (16.12) 27 39.00 (12.51) −0.84
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social and psychological functioning (score range
6–42). Higher scores indicate a greater degree of
problems. Both factors have excellent or good
internal consistency (Cronbach’s alpha 0.92 and 0.84
respectively).
Procedure
Approval of the research project was given by Ealing andWest
London Research Ethics Committee. Patients meeting
inclusion criteria and who were considered to be mentally
stable and suitable for this intervention were referred by
their clinical team. Referred patients were approached and
invited to participate in the study. The treatment was not
mandatory. A waiting-list controlled design was utilised
and group allocation was determined by the order of refer-
ral. Once group capacity had been reached, the remaining
patients were kept on a waiting-list for the following group.
After providing informed consent, participants completed
the self-reported measures at baseline (Time 1) and data
were obtained from clinical file reviews. The DBSP was com-
pleted by a member of the clinical team who knew the
patient well (most commonly the primary nurse). To reduce
inter-rater differences, the same informant completed the
questionnaire at both Time 1 and Time 2. Outcome mea-
sures were repeated again on completion of the group
(Time 2). The timing between assessments was generally
the same (16–18 weeks) for the R&R2MHP and TAU con-
ditions. A total of 5 groups, each with 5–8 participants
were delivered weekly. In addition group participants met
with their mentor (a member of the clinical team, most
commonly a health care or psychology assistant) between
sessions. Session logs were completed to record group
attendance. Researchers involved with data collection were
not involved in the delivery of the treatment. Data were
compiled centrally, input and scored using the Statistical
Program for Social Sciences (SPSS) database.
Statistical analysis
Descriptive statistics summarized demographics, clinical
and forensic baseline characteristics. Independent-samples
t tests were used to examine group differences at Time 1
(see Tables 1 and 2). Unadjusted mean scores and stand-
ard deviations on each of the outcome measures are pro-
vided in Table 3. A conservative intention to treat (ITT)
analysis was used to assess outcome with missing data im-
puted by ‘last observation carried forward’. Figure 1 pro-
vides a flowchart of patient participation and shows that
data were imputed at outcome for two treatment partici-
pants (7% of the treatment condition) and 9 control par-
ticipants (31% of the control condition). This design (ITT)
was adopted as this analysis is based on initial treatment
intent rather than the treatment which was eventually ad-
ministered [59]. Demographic and total score differencesbetween the two groups at Time 1 were not significant
for baseline and outcome measures, nevertheless in
order to minimize error variance a two-tailed analysis of
covariance (ANCOVA) was administered for each of the
dependent variables measuring differences between the
conditions in time using adjusted mean scores and stand-
ard deviations (see Table 3). The baseline Time 1 scores
therefore served as covariates for the dependent Time 2
variables. The effect size was analyzed using Cohen’s d for
efficacy measures.
In addition a post-hoc per protocol (PP) analysis was
performed on the subgroup of participants for whom full
data at Times 1 and 2 were available.
Power calculation
Sample size was determined by a power calculation
based on data obtained from a pilot study conducted by
Young, Chick and Gudjonsson [44]. Calculations at 80%
power with an alpha level of 0.05 suggested that 35 par-
ticipants per group will be needed in order to detect a
difference in the primary outcome measure with an ef-
fect size of 0.42 (pre-treatment mean 15.95 (SD = 10.83)
and post-treatment mean 11.36 (SD = 10.53).
Results
Baseline characteristics
All participants had a history of severe mental illness,
most commonly psychotic disorders, and violent offending
including with index offences of homicide (37%), sexual
violence (24%) and assault (39%). Independent t-tests
showed that there were no significant differences between
Table 2 Participant characteristics comparing group completers with non-completers at baseline (Time 1)
R&R2MHP completers R&R2MHP Non-completers
N M (SD) N M (SD) t-value
Age 24 36.67 (9.42) 6 43.00 (12.05) −1.40
Range = 22-59 Range = 31-63
Number of previous admissions 24 4.08 (4.40) 6 4.00 (5.62) 0.04
Range = 0-14 Range = 0-15
Number of previous convictions 24 10.88 (15.16) 6 8.83 (12.25) 0.31
Range = 0-65 Range = 0-33
PSYRATS total 24 7.83 (14.58) 6 8.00 (12.65) −0.03
SCID-II total 24 31.04 (12.08) 6 27.17 (14.76) 0.67
MVQ total 24 14.29 (11.20) 6 22.00 (14.30) −1.43
NAS-PI total 24 77.04 (16.24) 6 78.17 (20.48) −0.14
WAYS total 24 46.79 (20.96) 6 47.33 (29.94) −0.05
SPSI total 24 12.65 (3.07) 6 11.37 (4.55) 0.83
DBSP total 21 32.67 (13.50) 5 48.40 (21.50) −2.09*
*p < .05.
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of admissions and convictions, current psychotic symp-
toms (PSYRATS), antisocial personality traits (SCID-II),
and the total scores of outcome measures administered
pre-treatment (see Table 1).
Program completion rate
Of the 30 participants who started the R&R2MHP pro-
gram, 24 completed the program giving a group comple-
tion rate of 80%. Group completers attended a mean of 14
sessions (SD 1.38; range 12–16) and the non-completers
attended a mean of 7 sessions (SD 3.73; range 2–11).
Table 2 shows that there were no significant differences
between completers and non-completers in age, number
of previous convictions and admissions. Nor were signifi-
cant differences found between R&R2MHP completers
and non-completers on total scores of self-reported out-
come measures administered at Time 1. However the
non-completers were rated by informants to be signifi-
cantly more behaviorally disturbed on the DBSP.
Post-treatment outcome with ITT analysis
Table 3 presents unadjusted means and standard devia-
tions for each of the outcome measures at baseline (Time
1) and outcome (Time 2) for both R&R2MHP and TAU.
Results showed that being in the treatment group signifi-
cantly reduced violent attitudes with medium effect for
the Total MVQ score and Acceptance of Violence scale,
and with small effect for the Machismo scale. No signifi-
cant differences were found on NAS-PI scores assessing
anger reactions to provocation.
All treatment effects for the WAYS coping processes
were large. A significant improvement in effortful coping
was found for the Total score, together with applyingstrategies relating to confrontive, distancing, applying self-
control, seeking social support, accepting responsibility,
escape-avoidance, planful problem-solving and positive
reappraisal.
For social problem-solving, significant treatment effects
were found for developing a more positive problem-solving
orientation (large effect) and for engaging in a more ra-
tional problem-solving style (large effect) and avoidance
problem-solving style (small effect). No significant differ-
ences were found between groups for the SPSI-RS Total
score, negative problem solving orientation or impulsive/
carelessness style.
Staff ratings of disruptive behavior and social/psycho-
logical functioning were significantly improved with a
medium treatment effect for the DBSP Total score and
the Social/Psychological scale, and a small effect for the
Disruptive Behavior scale.
Post-treatment outcome with PP analysis
A similar pattern of results was found when a PP analysis
was conducted with the treatment effect increasing for all
significant outcomes, now ranging between medium and
large effect (see Table 4).
Discussion
This study aimed to investigate the completion rate and
effectiveness of the R&R2MHP program when delivered
to high risk MDOs with SMI. We found a group com-
pletion rate of 80%; the 20% dropout rate is considerably
lower than the 50% dropout rate reported by Cullen
et al. [46] for delivery of the 36-session R&R program to
MDOs. Hence the revisions that were made in R&R2
seem to have made the program more responsive to the
needs of this population who are a complex group of
Table 3 Post-treatment ITT outcome data comparing R&R2MHP and TAU conditions
Baseline (Time 1) Post-treatment (Time 2) ITT Time 2 outcome
R&R2MHP (N = 30) TAU (N = 29) R&R2MHP (N = 30) TAU (N = 29) F-value
Mean (SD) Mean (SD) Mean (SD) Mean (SD) (Cohen’s d)
MVQ Total 15.83 (12.02) 18.13 (13.45) 14.60 (11.22) 21.34 (14.67) 6.26 (.52)*
Machismo scale 8.60 (9.75) 10.79 (11.03) 8.00 (9.21) 12.86 (12.05) 4.33 (.45)*
Acceptance scale 7.23 (3.48) 7.34 (3.88) 6.60 (3.12) 8.48 (3.97) 7.62 (.53)**
NAS-PI total 77.27 (16.78) 79.24 (15.74) 80.00 (16.02) 81.00 (18.45) 0.01
Cognitive domain 27.90 (6.39) 28.07 (5.32) 28.33 (5.27) 28.59 (5.80) 0.02
Arousal domain 24.60 (6.03) 25.52 (6.12) 26.47 (7.07) 26.28 (6.63) 0.38
Behavior domain 24.77 (5.91) 25.66 (6.19) 25.20 (5.91) 26.14 (7.30) 0.06
WAYS total 46.90 (22.43) 42.83 (24.86) 61.50 (23.31) 33.41 (24.04) 35.56 (1.19)***
Confrontive coping 5.90 (3.22) 5.69 (3.26) 7.97 (3.77) 4.83 (3.26) 15.15 (0.89)***
Distancing coping 7.07 (3.59) 6.21 (3.60) 8.93 (4.22) 4.45 (3.58) 20.42 (1.14)***
Self-controlling coping 5.13 (2.53) 3.83 (2.56) 6.33 (2.89) 3.24 (2.84) 13.20 (1.08)***
Seeking social support coping 8.97 (7.92) 8.00 (5.70) 11.57 (7.10) 6.31 (4.80) 18.74 (0.87)***
Accepting responsibility coping 3.37 (2.34) 2.31 (2.59) 3.90 (2.50) 1.59 (2.38) 10.40 (0.95)**
Escape-avoidance coping 4.27 (3.23) 4.38 (3.91) 6.50 (3.03) 4.93 (3.57) 9.73 (0.47)**
Planful problem-solving coping 6.50 (3.62) 7.69 (6.99) 8.67 (3.35) 4.59 (4.20) 24.05 (1.07)***
Positive reappraisal coping 5.70 (4.11) 4.72 (4.38) 7.63 (4.63) 3.45 (4.35) 15.98 (0.93)***
SPSI-RS total 12.39 (3.36) 11.57 (2.49) 12.95 (3.32) 11.01 (3.84) 3.07
Positive problem orientation 11.20 (5.09) 9.41 (5.07) 12.13 (5.28) 7.86 (5.34) 10.73 (0.80)**
Negative problem orientation 6.43 (4.98) 6.41 (4.38) 6.00 (3.92) 5.59 (4.35) 0.22
Rational problem solving 10.50 (4.82) 8.14 (4.99) 10.80 (5.62) 6.17 (5.31) 6.72 (0.85)*
Impulsivity/carelessness 7.13 (4.88) 7.34 (5.13) 6.70 (4.34) 5.72 (5.21) 1.20
Avoidance style 6.17 (4.32) 5.90 (4.19) 5.57 (3.86) 4.00 (3.35) 4.20 (0.43)*
DBSP total 35.69 (16.12) 39.00 (12.51) 31.31 (12.96) 41.41 (13.34) 11.86 (0.77)**
Disruptive behavior 16.88 (10.43) 18.44 (10.04) 13.81 (8.11) 18.15 (9.76) 5.20 (0.48)*
Social and psychological 18.81 (7.77) 20.56 (6.89) 17.50 (7.93) 23.37 (6.93) 8.82 (0.79)**
*p < .05, **p < .01, ***p < .001.
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disorder, high rates of comorbidity, substance misuse,
entrenched antisocial attitudes and rigid cognitive styles.
The reduction in duration of the program together with
the supplementation of a mentor, who provides individ-
ual sessions that aim to transfer skills from the group
setting into daily activities, are likely to be important fac-
tors in limiting dropout [41].
These findings are consistent with results from a study
evaluating the feasibility of R&R2MHP in low and medium
secure settings, reporting a completion rate of 78% [43].
Cullen et al. caution that treatment dropout may be asso-
ciated with a high risk status [35], suggesting that comple-
tion rates may be inflated by the inclusion of lower risk
patients who are more advanced in the rehabilitation path-
way. The low dropout rates observed in the current study,
together with the 76% completion rate reported in a study
of R&R2 delivered to high risk patients with a primarydiagnosis of personality disorder [45], suggest that the re-
vised program is feasible for treating patients at all levels
of secure care.
It is essential to minimise dropout from OBPs as re-
search has indicated that those who do not complete
treatment display higher rates of re-offending compared
to those who do not engage in treatment at all [36].
Conversely, those who complete treatment programs
have lower reconviction rates compared to those who do
not complete treatment [38]. In the current study, group
non-completers were perceived by staff to be more
disruptive and have more social problems than those
who went on to complete the group. Their disruptive
behaviour and social problems may make their ability to
cope with group sessions more difficult and increase the
likelihood of dropout.
The second aim of the current study was to evaluate
the effectiveness of the program in high risk MDOs with
Table 4 Post-treatment PP outcome data comparing R&R2MHP and TAU conditions
Baseline (Time 1) Post-treatment (Time 2) PP Time 2 outcome
R&R2MHP (N = 28) TAU (N = 20) R&R2MHP (N = 28) TAU (N = 20) F-value
Mean (SD) Mean (SD) Mean (SD) Mean (SD) (Cohen’s d)
MVQ Total 15.83 (12.02) 18.13 (13.45) 13.42 (10.52) 21.75 (15.56) 6.98 (0.63)*
Machismo scale 8.60 (9.75) 10.79 (11.03) 7.08 (8.66) 12.95 (13.26) 4.90 (0.52)*
Acceptance scale 7.23 (3.48) 7.34 (3.88) 6.35 (3.12) 8.80 (3.53) 8.75 (0.74)**
NAS-PI total 77.27 (16.78) 79.24 (15.74) 79.12 (15.63) 79.25 (19.75) 0.00
Cognitive domain 27.90 (6.39) 28.07 (5.32) 28.00 (5.41) 28.35 (6.47) 0.03
Arousal domain 24.60 (6.03) 25.52 (6.12) 26.31 (7.11) 25.45 (6.80) 0.26
Behavior domain 24.77 (5.91) 25.66 (6.19) 24.81 (5.44) 25.45 (7.59) 0.09
WAYS total 46.90 (22.43) 42.83 (24.86) 62.08 (22.66) 25.65 (18.64) 44.83 (1.76)***
Confrontive coping 5.90 (3.22) 5.69 (3.26) 8.08 (4.00) 4.00 (2.71) 16.13 (1.19)***
Distancing coping 7.07 (3.59) 6.21 (3.60) 9.00 (4.37) 3.40 (3.32) 23.32 (1.44)***
Self-controlling coping 5.13 (2.53) 3.83 (2.56) 6.65 (2.87) 2.55 (2.72) 16.56 (1.47)***
Seeking social support coping 8.97 (7.92) 8.00 (5.70) 10.81 (4.32) 4.85 (4.08) 26.54 (1.42)***
Accepting responsibility coping 3.37 (2.34) 2.31 (2.59) 4.12 (2.36) .95 (1.88) 18.51 (1.49)***
Escape-avoidance coping 4.27 (3.23) 4.38 (3.91) 6.69 (3.07) 4.60 (2.37) 8.23 (0.76)**
Planful problem-solving coping 6.50 (3.62) 7.69 (6.99) 8.85 (3.51) 3.45 (3.38) 34.59 (1.57)***
Positive reappraisal coping 5.70 (4.11) 4.72 (4.38) 7.88 (4.68) 1.80 (3.22) 21.33 (1.51)***
SPSI-RS total 12.39 (3.36) 11.57 (2.49) 12.91 (3.26) 10.37 (4.05) 3.94
Positive problem orientation 11.20 (5.09) 9.41 (5.07) 11.96 (5.40) 6.65 (4.32) 13.24 (1.09)***
Negative problem orientation 6.43 (4.98) 6.41 (4.38) 6.12 (3.84) 5.70 (4.74) 0.26
Rational problem-solving 10.50 (4.82) 8.14 (4.99) 10.50 (5.95) 5.05 (4.89) 8.25 (1.00)**
Impulsivity/carelessness 7.13 (4.88) 7.34 (5.13) 6.42 (4.34) 5.65 (5.44) 1.08
Avoidance style 6.17 (4.32) 5.90 (4.19) 5.46 (3.47) 3.15 (2.68) 8.33 (0.75)**
DBSP total† 35.69 (16.12) 39.00 (12.51) 28.46 (9.11) 41.06 (13.99) 13.65 (1.07)***
Disruptive behavior† 16.88 (10.43) 18.44 (10.04) 11.46 (2.96) 17.06 (9.59) 8.14 (0.79)**
Social and psychological† 18.81 (7.77) 20.56 (6.89) 17.00 (8.77) 24.18 (7.90) 7.16 (0.86)*
*p < .05, **p < .01, ***p < .001.
† R&R2MHP N = 26 and TAU N = 1.
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found at outcome for self-reported violent attitudes,
coping processes and social problem-solving and for staff
rated behavior on wards. A conservative ITTanalysis found
small to large treatment effects all of which improved
(to medium and large) when a PP analysis was conducted.
As R&R2MHP’s primary aim is to reduce violent think-
ing and behavior, the present study used the self-report
MVQ as a primary outcome measure to assess attitudes
towards violence. Consistent with the findings of previous
studies [43,45] a significant treatment effect was found for
violent attitudes. This was endorsed by staff ratings of be-
havior on the wards indicating a significant reduction in
social difficulties and disruptive behavior.
By contrast, Young, Hopkin et al. [45] reported signifi-
cant results at outcome for NAS-PI anger cognitions
in offenders with a primary diagnosis of personality dis-
order which were not supported by the current study orby Rees-Jones et al. [43], the latter studies including of-
fenders with a history of SMI. Around half of the Young,
Hopkin et al. [45] sample had borderline personality dis-
order suggesting that the measure may be more helpful
in assessing emotionally labile patients.
Following treatment with the R&R2MHP program, an
improvement in SPSI-RS problem-solving styles has previ-
ously been reported for rational thinking [43] and, using a
similar program, for avoidance coping [45]. There was no
significant treatment effect for impulsivity/carelessness
style or the total problem-solving score, thus not sup-
porting the improvement on these scales reported previ-
ously when a similar program was delivered to high risk
personality disordered patients [45]. The current study
was slightly underpowered which may explain lack of sig-
nificance for these scales, or alternatively there may be
some variability in outcomes for MDO patient popula-
tions, even for those detained at the same level of security.
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fect has been reported indicating greater positive problem
orientation in MDOs (large effect) and the finding indi-
cates that participants in the treatment condition had de-
veloped more adaptive and constructive methods of social
problem-solving compared with those in the control con-
dition. The results provide further support for the exist-
ing empirical base which indicates that adaptive social
problem-solving can be learnt, even by individuals who are
considered to be high risk recidivists [34].
The largest treatment effect was found with respect to
coping processes; all outcomes with the exception of one
had a large effect size. In the pilot study, conducted on
SMI offenders detained in high and medium secure hos-
pital [44], the WAYS total score was not significant, al-
though the pilot had a small control sample of only twelve
patients. The present findings are however consistent with
a previous study which assessed coping processes using a
similar construct, the Coping Responses Inventory, and
reported small to large effects in an evaluation of the lon-
ger 36-session R&R program [60]. The present findings in-
dicate that the R&R2MHP program has a substantially
significant effect on coping processes. The increase in
confrontive coping is interesting and may not necessarily
mean that patients take a more aggressive position, but
are more prepared to assert themselves and have confi-
dence to confront and deal with interpersonal problems.
Similarly, the increase in distancing and avoidance coping
may reflect that patients engage in techniques that help
them to walk away from situations that are escalating and/
or anger provoking.
The study has several limitations. Patients were re-
ferred as appropriate for the group treatment by their
clinical team. Those who were not referred and the rea-
sons for exclusion were not recorded. The largest exclu-
sion categories were likely to be for reasons of mental
instability and risk of violence to the researchers, thus
reducing the generalisability of the study findings. It was
slightly underpowered which may have resulted in lower
effect sizes being identified. It has a quasi-experimental
controlled design and group allocation was not random-
ized, thus in order to control for variance at baseline
ANCOVA was used with baseline Time 1 scores covary-
ing for the dependent outcome scores and a more con-
servative ITT analysis selected as the primary analysis.
A randomised methodology was not applied for prag-
matic reasons because clinical teams did not wish to un-
necessarily delay treatment. Whilst differences in baseline
characteristics were not seen among those in the two arms
of the trial, numbers were small and it is possible that
other factors that influence outcome but were not mea-
sured differed between them. Given that those who re-
ceived active treatment were the first to be referred, it is
possible that they were more motivated to change theirbehavior. Missing data is common for a MDO sample,
however we were unable to collect a substantial amount
of informant Time 2 data due to high levels of staff turn-
over on wards. To avoid this in future, it is suggested that
informant data is obtained with collective input from the
clinical team, i.e. at ward round meetings. A record review
of behavior on the ward (i.e. a record of critical incidents)
was deemed unhelpful as previous review of such records
has indicated a low baseline of incidents, with most pa-
tients having no incidents formally recorded. Future re-
search should consider using a prospective assessment of
aggression, such as the Staff Observation Aggression Scale
Revised (SOAS-R0) [61], to obtain a record of every day,
including minor, incidents.
The findings contribute to the growing evidence for
treatment using R&R2MHP in different populations, how-
ever findings seem to differ between samples with differ-
ing patient characteristics and levels of security. Other
characteristics that may influence outcome include IQ
[62], self-esteem [63] impulsivity [64,65] and psychopathy
[35]. It would be helpful if objective predictors of treat-
ment outcome could be established, as this would mean
that services could identify those who are likely to benefit
from psychological interventions and those who require
preparatory precursor treatments [66]. Outcome measures
were administered by researchers who had not been in-
volved in the delivery of the intervention, nevertheless a
positive bias may still be present. Outcome measures
consisted purely of clinical indicators. In particular, future
research should include a cost-effective component in order
that health economic outcomes can be assessed. There was
no post-group follow up; other studies have reported an
increase in treatment effects at 3-month follow-up, indicat-
ing that the program has a sustained influence over time
[43,67]. Future research should use a randomized con-
trolled design with follow-up data that includes objective
assessments and reconviction data. It is of note that a meta-
analysis of the original R&R programme, on which the re-
vised R&R2 is based, found reductions in re-offending [34].
Conclusions
The results of the present study support the use of group
based cognitive-behavioral skills interventions with MDOs,
and the R&R2MHP program has the advantage of being a
manualised program which maximises program integrity.
In spite of the aforesaid limitations, results from the
present study contribute to its accruing evidence-base. Sig-
nificant improvements were found in violent attitudes,
coping processes and social problem-solving, and were en-
dorsed by ratings of ward behavior. We are living in an era
that demands cost-effective solutions for treating people
with mental illness and group-work programs are a re-
cognised target for development (The Sainsbury Centre
for Mental Health, 2008). R&R2MHP is nearly half the
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ive, hence representing a cost-effective program.
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